Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2000
03/09/2000WO2000012677A2 Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines
03/09/2000WO2000012555A1 Interleukin 18-binding protein
03/09/2000WO2000012554A1 Method for marked chemokine synthesis, marked chemokine and analysis kit
03/09/2000WO2000012553A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000WO2000012552A1 MAMMARY-SPECIFIC TRANSCRIPTION FACTOR BrEts
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012550A1 Novel polypeptide
03/09/2000WO2000012549A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000WO2000012548A1 Nucleic acid and polypeptide p10 of a borna disease virus (bdv) and their use for diagnostic and immunization purposes
03/09/2000WO2000012547A2 Benzodiazepines and benzothiazepines derivatives and hbsag peptides binding to annexins, their compositions and use
03/09/2000WO2000012546A1 MAMMALIAN elk POTASSIUM CHANNEL GENES
03/09/2000WO2000012545A2 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
03/09/2000WO2000012544A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000WO2000012542A2 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
03/09/2000WO2000012541A2 Cytotoxic peptides modified by bulky or lipophilic moieties
03/09/2000WO2000012538A1 Triple helix coil template having a biologically active ligand
03/09/2000WO2000012537A1 Process for the preparation of active somatotropin from inclusion bodies
03/09/2000WO2000012536A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
03/09/2000WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012532A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012528A1 Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
03/09/2000WO2000012526A1 NOVEL TARGETS OF p53 REGULATORY ACTIVITY
03/09/2000WO2000012525A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000WO2000012302A1 Bioriented polyethylene film with a high water vapor transmission rate
03/09/2000WO2000012139A1 Hypoxia regulated genes
03/09/2000WO2000012138A2 Cells expressing immunoregulatory molecules and uses therefor
03/09/2000WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012131A1 Multicomponent vaccines
03/09/2000WO2000012129A2 Salmonella typhi vaccine compositions
03/09/2000WO2000012128A2 Recombinant subunit vaccine against flaviviral infection
03/09/2000WO2000012126A1 Autoantibody inhibitors
03/09/2000WO2000012117A1 Wnt HOMOLOG NUCLEIC ACIDS, POLYPEPTIDES, METHODS, USES
03/09/2000WO2000012116A1 Method for administering insulinotropic peptides
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000012046A2 Pkdl nucleic acids, polypeptides, and diagnostic and therapeutic methods
03/09/2000WO2000011942A1 IDENTIFICATION OF A cDNA ASSOCIATED WITH ISCHEMIA IN HUMAN HEART TISSUE
03/09/2000WO2000000607B1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
03/09/2000WO1999067291A3 Site specific protein modification by mutagenesis
03/09/2000WO1999066327A3 Cartilage resorption assays
03/09/2000WO1999064570A9 Novel methods and interferon deficient substrates for the propagation of viruses
03/09/2000WO1999064068A9 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
03/09/2000WO1999063078A9 Retinal calcium channel (alpha)1f-subunit gene
03/09/2000WO1999063063A8 Cellular proteins which mediate herpesvirus entry
03/09/2000WO1999062548A9 Methods and compositions for diagnosing tauopathies
03/09/2000WO1999062537A9 Methods and agents for modulating the immune response and inflammation involving monocyte and dendritic cell membrane proteins
03/09/2000WO1999061580A3 Modification of cereal grain hardness via expression of puroindoline proteins
03/09/2000WO1999061477A3 Monoclonal antibody and assay for detecting piiinp
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000WO1999060013A3 Il-6 antagonist peptides
03/09/2000WO1999058671A9 Human and nematode homologues of the yeast longevity assurance gene lag1
03/09/2000WO1999058654A3 Transgenic plants with a modified activity of a plastidial adp/atp translocator
03/09/2000WO1999058653A3 Method for producing plants having an increased tolerance against drought and/or fungal attack and/or increased salt concentrations and/or extreme temperature by the expression of plasmodesmata-localized proteins
03/09/2000WO1999055915A3 IDENTIFICATION OF POLYMORPHISMS IN THE PCTG4 REGION OF Xq13
03/09/2000WO1999055873A3 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
03/09/2000WO1999053070A9 Flowering locus t (ft) and genetically modified plants having modulated flower development
03/09/2000WO1999050415A3 Protease-activated receptor par4 (zchemr2)
03/09/2000WO1999035170A9 Compositions and methods for the treatment of tumor
03/09/2000DE4090565C2 Rekombinantes Herpesvirus-Pockenvirus-Vakzin A recombinant herpesvirus poxvirus vaccine
03/09/2000DE19845277C1 Wolframin, a transmembrane protein and related DNA useful for diagnosis and therapy of Wolfram Syndrome, especially where there is a tendency to psychiatric disease
03/09/2000DE19845251A1 Peptide für Pharmatargeting Peptides for drug targeting
03/09/2000DE19839115A1 Klonierung und Expression von Rinder Estrogenrezeptor-beta Cloning and expression of bovine estrogen receptor-beta
03/09/2000DE19818680C1 A DNA double strand break repair protein, Nibrin, and related DNA useful for diagnosis and therapy of Nijmegen Breakage Syndrome and other diseases influenced by DNA-double-strand break repair
03/09/2000CA2777661A1 Multicomponent vaccines
03/09/2000CA2351547A1 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides
03/09/2000CA2348743A1 Laminin 5 for treatment of bone defects
03/09/2000CA2344591A1 Methods for improving the function of heterologous g protein-coupled receptors
03/09/2000CA2343046A1 Enhanced functional expression of g protein-coupled receptors
03/09/2000CA2342534A1 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000CA2341810A1 Cyclic prosaposin-derived peptides and uses thereof
03/09/2000CA2341766A1 Mammalian elk potassium channel genes
03/09/2000CA2341761A1 Novel polypeptide
03/09/2000CA2341755A1 Cells expressing immunoregulatory molecules and uses therefor
03/09/2000CA2341705A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000CA2341703A1 Salmonella typhi vaccine compositions
03/09/2000CA2341668A1 Receptor for underivatized, aqueous soluble beta-(1,3)-glucan
03/09/2000CA2341518A1 Hypoxia regulated genes
03/09/2000CA2341454A1 Method for administering insulinotropic peptides
03/09/2000CA2341360A1 Nucleic acid and polypeptide p10 of a borna disease virus (bdv) and their use for diagnostic and immunization purposes
03/09/2000CA2341324A1 Transgene assay using stable agrobacterium rhizogenes transformation
03/09/2000CA2341312A1 Maize ku70 orthologue and uses thereof
03/09/2000CA2341311A1 Staphylococcus aureus genes and polypeptides
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341148A1 Human membrane channel proteins
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2341051A1 Cell specific promoters of uncoupling protein 3
03/09/2000CA2340938A1 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
03/09/2000CA2340937A1 A new method of identifying non-host plant disease resistance genes
03/09/2000CA2340885A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000CA2340796A1 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340788A1 Recombinant nonstructural protein subunit vaccine against flaviviral infection
03/09/2000CA2340617A1 Genes associated with neurotransmitter processing
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340592A1 Phelix: a testis-specific protein expressed in cancer
03/09/2000CA2340579A1 Interleukin 18-binding protein
03/09/2000CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000CA2340326A1 Cytotoxic peptides modified by bulky or lipophilic moieties
1 ... 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 2198 2199 2200 2201 2202 2203 ... 2916